Regeneron starting late stage trials of coronavirus drug cocktail — Bristol-Myers pays Dragonfly Therapeutics $55M to bring NK cells to neuro diseases — JNJ in $480M-plus deal with Emergent for coronavirus vaccine supply — See more on our front page news Stay updated with the latest pharma-related coronavirus news on our new pageDismiss Notice
Please take our quick survey on how COVID-19 is impacting your job It will only take a minute or two to respond. The survey is confidential, and does not require registration. Thank you in advance for your participation. We will provide regular updates on results as responses accumulate.Dismiss Notice
The Politics of Healthcare
This board is for discussions about the effects of politics on the healthcare industry (pharmaceutical, device, etc). The board is moderated and posts will be reviewed before going live. Posts should be related to the subject matter and simple unsupported attacks on other users or others’ views will not be allowed.